Brief: Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
Thu 22:51
BRIEF-Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing Oct 22 (Reuters) - Gyre Therapeutics, Inc. GYRE.O:
GYRE THERAPEUTICS - ENTERS EMPLOYMENT AGREEMENT WITH YING LUO AS CEO - SEC FILING
GYRE THERAPEUTICS - ENTERS EMPLOYMENT AGREEMENT WITH THOMAS EASTLING AS CFO - SEC FILING
Source text: [ID:n0001140361-26-040506]
Further company coverage: GYRE.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Gyre Therapeutics
See all newsBrief: Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
Gyre Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Gyre Therapeutics, Inc. expected to post a loss of 13 cents a share - Earnings Preview
Brief: Gyre Therapeutics Reports Second Quarter 2026
Gyre Therapeutics Q2 revenue beats estimates on higher ETUARY sales volumes